Tag: Indian Council of Medical Research
Bharat Biotech’s COVAXIN Is Effective Against Delta Plus Variant Of COVID-19,...
The Hyderabad based Bharat Biotech International Private Limited manufactured COVAXIN has been found effective against the new Delta Plus variant of the Wuhan virus.
The...
India COVID-19 Cases Surge 2.26 Crores With 3.29 Lakh New Cases
The Novel Coronavirus (COVID-19) cases in India reported a dip in cases for the second consecutive day. On the 11th of May, India recorded...
India COVID-19 Cases Reports Slight Dip With 3.66 Lakh Fresh Cases
On the 10th May, India's Novel Coronavirus (COVID-19) single day cases reduced to 3.66 lakhs.
After recording over 4 lakh fresh cases for four consecutive...
India COVID-19 Continues To Rise With 4.18 Lakh New Cases, Total...
On the 7th of May, India reported the highest single day spike of the Novel Coronavirus or COVID-19. In the past 24 hours with...
India COVID-19 Cases Witness New Record of 4.12 Lakh Single Day...
After witnessing a decline in the Novel Coronavirus (COVID-19) cases, India once again reported the highest 4.12 lakh new cases.
On the 7th of May,...
India’s Daily COVID-19 Cases Witness Slight Fall, Reports 3.57 Lakh New...
India’s total tally of the Novel Coronavirus or COVID-19 witnessed a slight dip with 3.57 lakh cases. In the past 24 hours, India reported...
Telangana HC Directs Government To Follow ICMR Guidelines For COVID-19
Telangana High Court on the 18th of March, directed the Telangana Government to strictly implement the Novel Coronavirus or COVID-19 guidelines of the Indian...
ICMR Chief Says, Consent Of Volunteers Needed After Clinical Approvals
Balram Bhargava, the Chief of the Indian Council of Medical Research (ICMR) asked the Bharat Biotech International Private Limited to take consent from volunteers.
On...
Bharat Biotech And ICMR Prepared COVID-19 Vaccine Enters Phase 3 Trials
Hyderabad based pharma company, Bharat Biotech International Private Limited and the Indian Council Medical Research (ICMR) prepared vaccine, for the Novel Coronavirus or COVID-19...
NIMS Of Hyderabad Begins Phase III Trials Of COVID-19 Vaccine, COVAXIN
The Nizam's Institute of Medical Sciences (NIMS) of Hyderabad started the phase-III human clinical trials for COVAXIN.
The trials begin from the 16th of November.
A...
